Connecticut 2016 Regular Session

Connecticut House Bill HB05301 Compare Versions

OldNewDifferences
11 General Assembly Substitute Bill No. 5301
2-February Session, 2016 *_____HB05301PH____040416____*
2+February Session, 2016 *_____HB05301KID___030816____*
33
44 General Assembly
55
66 Substitute Bill No. 5301
77
88 February Session, 2016
99
10-*_____HB05301PH____040416____*
10+*_____HB05301KID___030816____*
1111
1212 AN ACT CONCERNING OPIOID ANALGESIC PRESCRIPTIONS ISSUED TO MINORS.
1313
1414 Be it enacted by the Senate and House of Representatives in General Assembly convened:
1515
1616 Section 1. (NEW) (Effective October 1, 2016) (a) A prescribing practitioner, as defined in section 20-571 of the general statutes, who is authorized to prescribe controlled substances in schedule II, III, IV or V, shall, prior to issuing the first prescription for an opioid analgesic in a single course of treatment to a patient under the age of eighteen:
1717
1818 (1) Review the patient's medical records, including, but not limited to, those maintained in the electronic prescription drug monitoring program established pursuant to section 21a-254 of the general statutes, if available;
1919
2020 (2) Assess whether the patient has ever suffered from or currently suffers from a psychiatric disability or substance abuse disorder and whether the patient has taken or is currently taking prescription medication for treatment of such disability or disorder;
2121
2222 (3) Discuss with the patient and the patient's parent or guardian the risks of addiction and overdose associated with opioid analgesics and the dangers of taking opioid analgesics with alcohol, benzodiazepines and other central nervous system depressants; and
2323
2424 (4) Obtain written consent for the prescription from the patient's parent or guardian on a form that shall be separate from any other document the prescribing practitioner uses to obtain informed consent for other treatment provided to the patient, and maintained in the patient's medical record. Such form shall contain:
2525
2626 (A) A statement indicating that the opioid analgesic prescribed has been identified as having a potential for abuse;
2727
2828 (B) A statement certifying that the prescribing practitioner discussed with the patient and the patient's parent or guardian the matters described in subdivision (3) of this subsection;
2929
3030 (C) The number of refills, if any, authorized by the prescription; and
3131
3232 (D) The signature of the patient's parent or guardian and the date of signing.
3333
3434 (b) The provisions of this section shall not apply if:
3535
3636 (1) The treatment of the patient is associated with or incident to a medical emergency;
3737
3838 (2) The treatment of the patient is associated with or incident to inpatient or outpatient surgery;
3939
4040 (3) The treatment of the patient is rendered in a hospital, emergency facility, ambulatory surgical center, nursing home, respite care program, residential care facility or freestanding rehabilitation facility, unless the prescribing practitioner maintains a primary office on the premises of the hospital, emergency facility, ambulatory surgical center, nursing home, respite care program, residential care facility or freestanding rehabilitation facility;
4141
4242 (4) The prescription is issued at the time of discharge from a hospital, emergency facility, ambulatory surgical center, nursing home, respite care program, residential care facility or freestanding rehabilitation facility; or
4343
4444 (5) In the prescribing practitioner's judgment, complying with the requirements of this section would be a detriment to the patient's health, safety or welfare.
4545
4646 (c) For the purposes of this section, "parent or guardian" means the parent or guardian of a patient under the age of eighteen or, in the case of a patient under the age of eighteen who is an emancipated minor, the patient.
4747
4848
4949
5050
5151 This act shall take effect as follows and shall amend the following sections:
5252 Section 1 October 1, 2016 New section
5353
5454 This act shall take effect as follows and shall amend the following sections:
5555
5656 Section 1
5757
5858 October 1, 2016
5959
6060 New section
6161
62+Statement of Legislative Commissioners:
63+
64+In Section 1(a)(4)(B), "subdivision (3) of subsection (a) of this section" was changed to "subdivision (3) of this subsection" for accuracy.
65+
6266
6367
6468 KID Joint Favorable Subst. -LCO
65-PH Joint Favorable
6669
6770 KID
6871
6972 Joint Favorable Subst. -LCO
70-
71-PH
72-
73-Joint Favorable